| scholarly article | Q13442814 |
| P50 | author | Brian Hemmings | Q4964012 |
| Reinhard Dummer | Q32650033 | ||
| P2093 | author name string | Yuhua Wang | |
| Alfred Zippelius | |||
| Peter Cron | |||
| Mario Mandalà | |||
| Andreas Wicki | |||
| Mitchell P Levesque | |||
| Stephan Dirnhofer | |||
| Daniela Massi | |||
| Fengyuan Tang | |||
| Taha Merghoub | |||
| Curzio Rüegg | |||
| Daniela Taverna | |||
| Francesca Orso | |||
| Giulio C Spagnoli | |||
| Huifang Tang | |||
| Christel Genoud | |||
| Tim Roloff | |||
| Reto Ritschard | |||
| Gongda Xue | |||
| Manuele G Muraro | |||
| Petra Hirschmann | |||
| Vincent Prêtre | |||
| Debby Hynx | |||
| Sandrine Bichet | |||
| Reto Kohler | |||
| Alexandra G Meyer | |||
| P2860 | cites work | Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF | Q24298749 |
| Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib | Q24594790 | ||
| Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma | Q24597152 | ||
| Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation | Q24629474 | ||
| Improved survival with vemurafenib in melanoma with BRAF V600E mutation | Q24631953 | ||
| Autophagy modulation as a potential therapeutic target for diverse diseases | Q27010076 | ||
| Autophagy-mediated tumor promotion | Q27011920 | ||
| Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma | Q27777363 | ||
| Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. | Q27851711 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Autophagy fights disease through cellular self-digestion | Q27860902 | ||
| AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 | Q28506431 | ||
| Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome | Q28508181 | ||
| Autophagy regulates phagocytosis by modulating the expression of scavenger receptors | Q28589932 | ||
| The role of autophagy during the early neonatal starvation period | Q29547489 | ||
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
| Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis | Q29614481 | ||
| COT drives resistance to RAF inhibition through MAP kinase pathway reactivation | Q29615032 | ||
| Mechanisms of cancer drug resistance | Q29615849 | ||
| EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer | Q29616360 | ||
| Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion | Q29617359 | ||
| TGF-beta-induced epithelial to mesenchymal transition | Q29619820 | ||
| MERTK receptor tyrosine kinase is a therapeutic target in melanoma. | Q30539324 | ||
| SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes | Q33867572 | ||
| Phagocytosis and clearance of apoptotic cells is mediated by MER. | Q33946282 | ||
| Circumventing Cancer Drug Resistance in the Era of Personalized Medicine | Q34274940 | ||
| Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma | Q34372987 | ||
| Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma | Q34664981 | ||
| Principles and current strategies for targeting autophagy for cancer treatment | Q34787732 | ||
| Cleavage of Mer tyrosine kinase (MerTK) from the cell surface contributes to the regulation of retinal phagocytosis | Q35103962 | ||
| Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase | Q36371130 | ||
| Deconvoluting the context-dependent role for autophagy in cancer | Q36876716 | ||
| MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis | Q37052927 | ||
| The double-edged sword of autophagy modulation in cancer | Q37331327 | ||
| TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF- Mutant Melanoma | Q37401151 | ||
| Role of autophagy in cancer prevention | Q37898320 | ||
| Regulatory networks defining EMT during cancer initiation and progression | Q38076317 | ||
| Overcoming resistance to rapalogs in gliomas by combinatory therapies | Q38080364 | ||
| Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. | Q38111226 | ||
| Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. | Q38131219 | ||
| Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling | Q38824661 | ||
| Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. | Q39020884 | ||
| Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma | Q39096897 | ||
| Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. | Q39348238 | ||
| Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme | Q39370401 | ||
| Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial | Q39537308 | ||
| Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. | Q39541632 | ||
| A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status | Q39802879 | ||
| Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial | Q40875359 | ||
| Autophagy-deficient mice develop multiple liver tumors | Q42099409 | ||
| The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer | Q54298179 | ||
| A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. | Q54406377 | ||
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| P304 | page(s) | 69204-69218 | |
| P577 | publication date | 2017-05-25 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition | |
| P478 | volume | 8 |
| Q64974212 | Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor. |
| Q53694245 | The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma |
| Q57821061 | The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study |
Search more.